Dextran Sulfate Sodium Salt-Induced Colitis Aggravates Gut Microbiota Dysbiosis and Liver Injury in Mice With Non-alcoholic Steatohepatitis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dextran Sulfate Sodium Salt-Induced Colitis Aggravates Gut Microbiota Dysbiosis and Liver Injury in Mice With Non-alcoholic Steatohepatitis
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-11-02
DOI
10.3389/fmicb.2021.756299
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR‐30c inhibits angiogenesis by targeting delta‐like ligand 4 in liver sinusoidal endothelial cell to attenuate liver fibrosis
- (2021) Tianyi Gu et al. FASEB JOURNAL
- Butyrate and the Fine-Tuning of Colonic Homeostasis: Implication for Inflammatory Bowel Diseases
- (2021) Naschla Gasaly et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A High-Fat/High-Protein, Atkins-Type Diet Exacerbates Clostridioides (Clostridium) difficile Infection in Mice, whereas a High-Carbohydrate Diet Protects
- (2020) Chrisabelle C. Mefferd et al. mSystems
- Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
- (2020) Judith Aron-Wisnewsky et al. Nature Reviews Gastroenterology & Hepatology
- Sutterella Species, IgA-degrading Bacteria in Ulcerative Colitis
- (2020) Nadeem O. Kaakoush TRENDS IN MICROBIOLOGY
- Microbiota and Fatty Liver Disease—the Known, the Unknown, and the Future
- (2020) Sonja Lang et al. Cell Host & Microbe
- Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States
- (2020) Zobair M. Younossi et al. Clinical Gastroenterology and Hepatology
- SCFAs alleviated steatosis and inflammation in mice with NASH induced by MCD
- (2020) Mingjuan Deng et al. JOURNAL OF ENDOCRINOLOGY
- Nonalcoholic Fatty Liver Disease Is Common in IBD Patients However Progression to Hepatic Fibrosis by Noninvasive Markers Is Rare
- (2020) Gabrielle Ritaccio et al. DIGESTIVE DISEASES AND SCIENCES
- Landscape of Intercellular Crosstalk in Healthy and NASH Liver Revealed by Single-Cell Secretome Gene Analysis
- (2019) Xuelian Xiong et al. MOLECULAR CELL
- Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history
- (2019) Salvatore Magrì et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Increased liver localization of lipopolysaccharides in human and experimental non‐alcoholic fatty liver disease
- (2019) Guido Carpino et al. HEPATOLOGY
- Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells
- (2018) Meng Li et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
- (2018) Chris Estes et al. JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease
- (2018) Alessandro Sartini et al. Cell Death & Disease
- Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: Attention to the gut-vascular barrier dysfunction
- (2018) Chunwei Cheng et al. LIFE SCIENCES
- iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data
- (2018) Steven Xijin Ge et al. BMC BIOINFORMATICS
- The role of the microbiome in NAFLD and NASH
- (2018) Aleksandra A Kolodziejczyk et al. EMBO Molecular Medicine
- Proteobacteria: A Common Factor in Human Diseases
- (2017) G. Rizzatti et al. Biomed Research International
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota
- (2016) Jérôme Boursier et al. HEPATOLOGY
- The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
- (2016) Elena Buzzetti et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The role of the gut microbiota in NAFLD
- (2016) Christopher Leung et al. Nature Reviews Gastroenterology & Hepatology
- Short-Chain Fatty Acids Protect Against High-Fat Diet–Induced Obesity via a PPARγ-Dependent Switch From Lipogenesis to Fat Oxidation
- (2015) Gijs den Besten et al. DIABETES
- The Triggering Receptor Expressed on Myeloid cells-1: A new player during acute myocardial infarction
- (2015) Lemarié Jérémie et al. PHARMACOLOGICAL RESEARCH
- NAFLD in Asia—as common and important as in the West
- (2013) Geoffrey C. Farrell et al. Nature Reviews Gastroenterology & Hepatology
- Molecular Characterization of the Fecal Microbiota in Patients with Nonalcoholic Steatohepatitis – A Longitudinal Study
- (2013) Vincent Wai-Sun Wong et al. PLoS One
- Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice
- (2012) Tiphaine Le Roy et al. GUT
- Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH
- (2012) Lixin Zhu et al. HEPATOLOGY
- DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH
- (2011) Erwin Gäbele et al. JOURNAL OF HEPATOLOGY
- Generalizability of the Nonalcoholic Steatohepatitis Clinical Research Network Histologic Scoring System for Nonalcoholic Fatty Liver Disease
- (2010) Ravi Juluri et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation